Anktiva

This listing's Product Keywords identify Anktiva as nogapendekin alfa inbakicept (N-803), an IL-15 superagonist immunotherapy used for BCG-unresponsive non-muscle-invasive bladder cancer — however, the supplier's own descriptive text instead discusses an unrelated FGF23-targeting antibody for X-linked hypophosphatemia, an apparent mismatch in the source listing that should not be taken as a reliable description of this specific product. It is offered at injection grade, meeting ChP, USP, BP, EP and JP standards, traded rather than manufactured by VuRoyal (SuQian) Pharmaceutical Company LLC, and sold into North America and Central/South America.